Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

BUY
$0.55 - $0.82 $14 - $21
26 Added 3.07%
873 $0
Q1 2023

May 12, 2023

BUY
$0.65 - $1.37 $196 - $415
303 Added 55.7%
847 $0
Q4 2022

Feb 13, 2023

SELL
$0.6 - $1.41 $298 - $700
-497 Reduced 47.74%
544 $0
Q3 2022

Nov 14, 2022

SELL
$0.94 - $2.56 $6 - $17
-7 Reduced 0.67%
1,041 $1,000
Q2 2022

Aug 12, 2022

SELL
$1.78 - $5.02 $10,099 - $28,483
-5,674 Reduced 84.41%
1,048 $2,000
Q1 2022

May 16, 2022

SELL
$3.54 - $8.08 $22,532 - $51,429
-6,365 Reduced 48.64%
6,722 $33,000
Q4 2021

Feb 14, 2022

BUY
$5.69 - $7.83 $69,264 - $95,314
12,173 Added 1331.84%
13,087 $99,000
Q3 2021

Nov 15, 2021

SELL
$7.88 - $14.0 $94,307 - $167,552
-11,968 Reduced 92.9%
914 $7,000
Q2 2021

Aug 16, 2021

BUY
$13.81 - $23.25 $120,298 - $202,530
8,711 Added 208.85%
12,882 $179,000
Q1 2021

May 13, 2021

SELL
$17.65 - $24.16 $269,091 - $368,343
-15,246 Reduced 78.52%
4,171 $87,000
Q4 2020

Feb 09, 2021

SELL
$12.83 - $17.84 $73,143 - $101,705
-5,701 Reduced 22.7%
19,417 $323,000
Q3 2020

Nov 05, 2020

BUY
$11.01 - $18.52 $5,075 - $8,537
461 Added 1.87%
25,118 $427,000
Q2 2020

Aug 13, 2020

BUY
$11.11 - $24.72 $32,130 - $71,490
2,892 Added 13.29%
24,657 $409,000
Q1 2020

May 14, 2020

BUY
$10.74 - $16.32 $233,756 - $355,204
21,765 New
21,765 $252,000

Others Institutions Holding HARP

About Harpoon Therapeutics, Inc.


  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.